Flourishing Medical Tourism & Adoption of Minimally Invasive Surgeries Boost the Growth of Transcatheter Embolization and Occlusion Devices Market to reach US$4.8 Billion by 2024

The Transcatheter Embolization and Occlusion Devices (TEO) devices market is fueled by a number of factors, including an increase in the adoption of minimally invasive surgeries, a rise in the prevalence of cancer, technological innovations, and changing demographics and lifestyle leading to an increase in peripheral vascular diseases. “Embolization is a minimally invasive surgery that marks a significant advancement in medical technologies,” the author of the report states. “The adoption of minimally invasive surgeries has increased significantly over the years owing to the various advantages they present, including less post-operative pain, reduced blood loss, shorter hospital stay, and faster recovery.” Cancer is one of the leading causes of mortality and morbidity around the world and the rising prevalence of cancer globally has driven the demand for chemembolization and radioembolization. This has, in turn, boosted the demand for transcatheter embolization and occlusion devices.

Download PDF Brochure of Report - http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2242

In contrast, frequent product recalls, stringent regulations governing product approvals, the lack of skilled professionals, and the lack of reimbursement policies in emerging markets threaten to impede the global market for transcatheter embolization and occlusion devices.

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major embolization therapies in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation, and various international and national databases. The report provides estimated market size in terms of US$ Mn for each product type, application, end-user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering number of products used in the procedures and their market demand as per their use, number of products launched, average cost of products of each sub segment, trends in industry, end-user trend, and adoption rate across all geographies. The revenue generated for applications was calculated on the basis of prevalence of diseases and number of devices available for the treatment of particular disease.

The report also provides volume in terms of number of units for each product type, generated by average selling price for each product by different manufacturers across the geographies. Market trends and demand has been considered in addition to the above parameters. The adoption rate for the procedures in various geographies has been studied in detail to gain further insights in the analysis.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on type of product, application, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that influences the TEO devices market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved from drug manufacturing to their final reach to the end-users.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide on the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the transcatheter embolization and occlusion devices market.

Browse Report with Complete TOC - http://www.transparencymarketresearch.com/transcatheter-embolization-occlusion-devices-market.html

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.